Feds Extend Immunity To Ex-Retrophin Exec Over Hacking Claim
By Jack Newsham · November 14, 2017, 8:57 PM EST
A former executive at Martin Shkreli's drug company Retrophin Inc. struck a nonprosecution agreement with Brooklyn federal prosecutors on Tuesday and continued testifying after lawyers for accused securities fraud co-conspirator and ex-BigLaw...
To view the full article, register now.